中新网评:处理核污水绝不是日本自家私事******
中新网北京1月19日电(蒋鲤)日本政府近日称,将于2023年春夏期间开始向海洋排放经过处理的福岛第一核电站核污水。日本罔顾国内民众及周边国家的屡屡反对,企图将核污水“一倒了之”,把一件关乎全球海洋生态环境和公众健康的事当成了自家私事。
资料图:日本福岛第一核电站。2011年,福岛核电站事故发生后,大量放射性物质泄漏到大气层和太平洋,对周围环境造成了难以逆转的伤害,数十万人被迫撤离该地区。时至今日,作为日本邻国之一的韩国仍未解除福岛海鲜禁令。
日本以核污水存储能力即将达到上限为由,在2021年4月13日,正式决定将福岛第一核电站核污水排入太平洋。过去一年多,日本政府和东京电力公司一直在持续推进核污水排海计划。
日本政府辩称,这些核污水经多核素处理系统(ALPS)处理后很安全,甚至“可以喝”,这样的表态无疑在愚弄大众。
事实上,经过处理的核污水仍含有多种放射性物质,核污水一旦排放入海就无法回收,长期来看,将会给海洋生态带来难以估量的潜在威胁,最终危害人类健康。
因此,核污水排海计划推出后,遭到日本民众强烈反对。日本《朝日新闻》2022年3月公布的问卷调查显示,福岛县、宫城县和岩手县受访的42个市町村长中,约六成反对东京电力公司福岛第一核电站核污水排放入海。日本全国渔业协会联合会也多次申明立场,反对该计划。
日本政府认为,核污水排海是最便宜、最省事的解决方案,但此举却将周边国家乃至全世界置于核污染风险中。太平洋非日本一家之海,核污水会随着洋流流动,其影响势必会跨越国界,危害周边国家乃至整个国际社会的公共福祉和利益。
《韩国经济新闻》发文称,相关研究认为,福岛核污水如果排放入海,约7个月后将到达济州等韩国海域,该国水产业和旅游业将遭受相当大的损失。
德国南极海洋机构也曾发出警告,若日本将所有核污水排入海中,不到半年,整个太平洋都将面临高度辐射威胁,包括远在大洋另一端的美国。太平洋地区人民更是对日本该计划持反对意见。
日本作为《联合国海洋法公约》缔约国,有义务保护海洋环境。然而,在核污水排海方案的正当性、核污水数据的可靠性、净化装置的有效性、环境影响的不确定性等问题上,日本未能作出科学、可信的说明。
国际原子能机构技术工作组虽已三次赴日实地考察评估,但尚未就日排海方案的安全性给出结论,并且对日本提出诸多澄清要求和整改意见。在此情况下,日本仍执意推进核污水排海工程建设,这是极不负责任的行为。
太平洋不是日本的下水道,日本必须正视各方合理关切,在与周边国家等相关利益方和国际原子能机构充分协商后,制定合理的核污水处理方案。日本也要着眼长远,若只顾眼前,执意将核污水排放入海,不仅其自身,周边国家乃至全世界都将为之买单,其后果必将会危害数代人。
Fukushima water disposal by no means Japan’s own business
By John Lee
(ECNS) -- Japan has announced it will release treated wastewater from the wrecked Fukushima Daiichi Nuclear Power Plant into the Pacific Ocean this year.
Although Fukushima wastewater disposal affects global marine ecological environment protection and public health, Japan has turned a deaf ear to domestic and international opposition to dumping the contaminated water into the sea, treating the "global" matter as its own business.
The Fukushima accident in 2011 had sent large quantities of radiation into the atmosphere and the Pacific Ocean, causing irreversible damage to the surrounding environment, and hundreds of thousands of people were forced to evacuate the area. South Korea still maintains its import ban on Japanese seafood from areas affected by the Fukushima nuclear disaster.
On April 13, 2021, Japan announced it had decided to discharge contaminated radioactive wastewater in Fukushima Prefecture into the sea due to dwindling storage space, with the Japanese government and plant operator Tokyo Electric Power Company Holdings Inc. promoting the release plan over the past year.
The Japanese government argues that the water treated by an advanced liquid processing system, or ALPS, is safe and drinkable, which is undoubtedly fooling the public.
In fact, the treated wastewater still includes a variety of radioactive substances and can’t be recycled once discharged into the sea, which will pose a great threat to marine ecology and ultimately endanger human health in the long run.
Therefore, the discharge plan has been strongly opposed in Japan. According to a questionnaire conducted by The Asahi Shimbun, nearly 60 percent of mayors of 42 municipalities in Iwate, Miyagi and Fukushima prefectures oppose the discharge plan. The National Fisheries Cooperative Federation of Japan has also repeatedly stated its opposition in public.
The Japanese government believes that dumping Fukushima wastewater into the sea is the cheapest and most convenient solution, but neighboring countries and even the whole world will be at risk of nuclear pollution.
The Pacific Ocean doesn’t belong to Japan and the wastewater flow along oceanic currents will surely break boundaries and endanger public welfare and the interests of neighboring countries and even the international community.
The Korea Economic Daily reported that related research concluded that if contaminated water from Fukushima is released into the ocean, it would only take seven months for the contaminated water to reach the shores of Jeju Island, with the country's aquaculture and tourism suffering considerable losses.
According to the calculation of a German marine scientific research institute, radioactive materials will spread to most of the Pacific Ocean within half a year from the date of discharge, and the U.S. and Canada will be affected by nuclear pollution. People in the Pacific region also oppose the discharge plan.
As a participant of the United Nations Convention on the Law of the Sea, Japan has the obligation of protecting the marine environment.
However, it hasn’t offered a full and convincing explanation on issues like the legitimacy of the discharge plan, the reliability of data on the nuclear-contaminated water, the efficacy of the treatment system or the uncertainty of environmental impact.
Though the IAEA has yet to complete a comprehensive review after three investigations in Japan, the Japanese side has been pushing through the approval process for its discharge plan and even started building facilities for the discharge. It is rather irresponsible for Japan to act against public opinion at home and concerns abroad.
The Pacific Ocean is not a private Japanese sewer. The country must seriously heed the voices of the international community and make a reasonable plan for the Fukushima wastewater disposal after full consultation with stakeholders and international agencies.
If it only seeks instant interest and insists on discharging the contaminated water into the sea, not only itself, but also its neighboring countries and the entire world will pay for the decision and several generations will be forced to bear the consequence.
新冠病毒感染强调综合治疗****** 近期,一些治疗新冠的抗病毒药物受到高度关注。与病毒“交战”,真有所谓的“特效药”吗?静脉用丙种球蛋白突然成为“抢手货”,价格也随之猛涨,公众有必要储备吗?国家卫生健康委邀请相关领域的专家就此进行了解读。 “目前,新冠病毒感染的治疗仍然强调综合治疗,包括对症支持治疗、早期抗病毒治疗、早期氧疗、免疫治疗、抗凝治疗等,对于重要的脏器衰竭,如呼吸衰竭等,还要有呼吸支持治疗以及脏器功能的支持等。”北京大学第一医院感染科主任王贵强介绍,抗病毒治疗是综合治疗的一个重要组成部分,第十版诊疗方案中抗病毒治疗包括口服的小分子抗病毒药物。 “但病毒感染应该说没有特效药。有一些针对病毒的,比如能够抑制和干扰病毒复制的药物,可在病程早期使用。”北京市呼吸疾病研究所所长童朝晖介绍,有的药物要求5天以内使用,其实最有效的时间是2天以内。病毒刚进入人体、刚开始复制的时候使用药物干扰病毒的复制,能够减轻病毒的载量,进而减少对人体免疫系统的攻击,再加上自身的抵抗力,就能减少它向重型、危重型发展。 “小分子口服抗病毒药通过直接抑制病毒复制来清除或抑制病毒,减轻临床症状,缩短病程,降低重症风险,最终降低住院和死亡的风险。它的特点是口服,比较方便,在医院、社区、诊所、门诊都可以使用。”王贵强建议,老年人、有基础病的、没有打疫苗的等重症高风险人群应优先使用,降低重症风险,一般人群感染后使用价值并不大。 童朝晖提醒:“如果病程超过5天,已经进展为重症甚至危重症的时候,这些抗病毒药是没有效果的。” 抗病毒药物使用不当会出现哪些风险?王贵强说,抗病毒药物都有一定副作用,也有药物之间相互作用。 “像服用他汀类药物时就不能同时使用奈玛特韦这类药物,否则就会出现药物之间相互作用。有些肝肾功能严重损害的病人,有时候要调整剂量,甚至不能使用,所以一定要在医生指导下来使用这类抗病毒药。”王贵强说。 “有的群众一听‘特效药’,就给老人备点放在家里,老人就直接使用了,如果没有阅读说明书,风险更高。”童朝晖建议,服用药物必须认真阅读说明书,或是在专业医师的指导下使用。 近日,静脉用丙种球蛋白也引发不少网友求购。对此,王贵强介绍,静脉用丙种球蛋白能够减少炎症反应,但只建议在治疗重症病人时使用,“基本都是进入ICU的病人才需要使用,而且要在出现炎症因子风暴等特定情况下使用才有效果,不适合在家里使用,也没有预防新冠感染的作用,因此不建议在家里储备”。(记者 崔兴毅) 中国网客户端 国家重点新闻网站,9语种权威发布 |